Follow the 폴라리스AI파마 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Technology sector, 폴라리스AI파마 has logged 14 reports. Market capitalisation: €7.7m. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 폴라리스AI파마. The full history is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,057 of 29,064 companies
18.3
score / 100
Value
12
Quality
25
FCF yld-11%
Earn yld-27%
EV/EBITDA·
ROE-63%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Polaris AI Pharma es una empresa de tecnología que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones de inteligencia artificial para la industria farmacéutica.